Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0000950103-24-011770
Filing Date
2024-08-06
Accepted
2024-08-06 16:26:55
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 dp216154_s3.htm S-3 520520
2 EXHIBIT 1.2 dp216154_ex0102.htm EX-1.2 198865
3 EXHIBIT 5.1 dp216154_ex0501.htm EX-5.1 27601
4 EXHIBIT 5.2 dp216154_ex0502.htm EX-5.2 18858
5 EXHIBIT 23.1 dp216154_ex2301.htm EX-23.1 1999
6 EXHIBIT 107 dp216154_exfilingfees.htm EX-FILING FEES 53349
7 GRAPHIC image_001.jpg GRAPHIC 3459
8 GRAPHIC image_002.jpg GRAPHIC 3456
9 GRAPHIC image_003.jpg GRAPHIC 4087
  Complete submission text file 0000950103-24-011770.txt   837796
Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-281288 | Film No.: 241179751
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)